Sushant Singh Rajput Death Case: Showik Chakraborty & Samuel Miranda Test Negative For Covid-19; Know Top Developments

On September 4, Rhea Chakraborty’s brother Showik Chakraborty and Sushant Singh Rajput’s house manager Samuel Miranda were arrested by the NCB. Read on.

New Delhi: The NCB raided Rhea Chakraborty and Samuel Miranda’s house on Friday. After almost 10 long hours of interrogation, the Narcotics Control Bureau (NCB) arrested her brother and Sushant Singh Rajput’s house manager Samuel Miranda on September 4 related to the ‘drug angle’ in the SSR death case. Reportedly, both Showik and Miranda will be presented before the court on Saturday at 12 pm and NCB will seek their custody for further investigation. The agency has arrested them under IPC sections 20 (B), 28 (counterfeit), 29, and 27 (A). Showik Chakraborty, Samuel Miranda, Zaid and Kaizen Ibrahim were taken to Sion Hospital in Mumbai for COVID-19 test,  KPS Malhotra, Deputy Director (operations), Narcotics Control Bureau (NCB) said. As per sources, they have tested negative. In the latest development, Showik and Samuel Miranda  were taken for their medical tests and they will also be presented before the court today at 12 pm reportedly. Sushant Singh Rajput’s staff Deepesh Sawant has not been arrested by the NCB but his statement will be recorded as a witness. Based on reports, Showik Chakraborty confessed that Rhea asked him and Samuel Miranda to obtain drugs. Also, Zaid Vilatra and Abdul Basit Parihar, the alleged drug peddlers, who have been arrested by the NCB have applied for bail in Mumbai Sessions Court. Meanwhile, reportedly, the NCB team has also collected crucial data evidence including phone, and laptop after they raided Rhea Chakraborty’s residence yesterday. In the Sushant Singh Rajput death case, NCB is the third central agency to join the probe after the ‘drug angle’ emerged in the case. They registered a case against Rhea, her brother Showik, talent manager Jaya Saha, Shruti Modi, and Goa-based hotelier Gaurav Arya under Sections 20 (b), 28, and 29 of the Narcotic Drugs and Psychotropic Substances Act. Watch this space for the latest updates.